Expanded phase 2b trial of Donaperminogene-seltoplasmid for Amyotrophic Lateral Sclerosis
Latest Information Update: 17 Mar 2021
At a glance
- Drugs Donaperminogene seltoplasmid (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Therapeutic Use
- 17 Mar 2021 New trial record
- 10 Mar 2021 According to a Helixmith media release, the company expect to initiate this study, if the results for phase IIa trial are positive.